AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26997192 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive-norms-feedback-only condition
Number of subjects: 176
Study 26997192 — intervention group
Group type: EXPERIMENTAL
Intervention: Descriptive-plus-injunctive-message condition
Number of subjects: 176
Study 26997192 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 176
Study 25191766 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-lipoic acid (LA) supplementation (500 mg/day) for three months
Number of subjects: 56
Study 22027944 — intervention group
Group type: EXPERIMENTAL
Intervention: Red ginseng (3 g per day, including 60 mg of ginsenosides)
Number of subjects: 72
Study 22027944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in the title
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in the Results section
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in the Conclusions section
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin focusing only on treatment effectiveness
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in the main-text Results section
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in the main-text Discussion section
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in the main-text Conclusions section
Number of subjects: 72
Study 20501928 — intervention group
Group type: EXPERIMENTAL
Intervention: Reports with spin in at least 2 sections of the main text
Number of subjects: 72
Study 18520980 — intervention group
Group type: EXPERIMENTAL
Intervention: 200-mg retarded-release levodopa/carbidopa (LD/CD)
Number of subjects: 12
Study 18520980 — intervention group
Group type: EXPERIMENTAL
Intervention: 150-mg levodopa/carbidopa/entacapone (LD/CD/EN)
Number of subjects: 12
Study 16145047 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 5187
Study 16145047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5187
Study 12105354 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-MHz convex probe
Number of subjects: 20
Study 12105354 — intervention group
Group type: COMPARATOR
Intervention: 7.5-MHz linear probe
Number of subjects: 20
Study 10027435 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium
Number of subjects: 20
Study 10027435 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol
Number of subjects: 20
Study 7538240 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 W for 180 s
Number of subjects: 29
Study 7538240 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 W for 60 s
Number of subjects: 29
Study 7538240 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 W for 180 s and 50 W for 60 s (both groups)
Number of subjects: 29
Study 7538240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 29
Study 1828336 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (2.04 g/d)
Number of subjects: 33
Study 1828336 — intervention group
Group type: COMPARATOR
Intervention: safflower oil (4.8 g/d of linoleic acid)
Number of subjects: 33
Study 116282 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxprenolol (480 mg)
Number of subjects: 6
Study 116282 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam (2 mg)
Number of subjects: 6
Study 30612727 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-treated diabetes mellitus (ITDM)
Number of subjects: 0
Study 30612727 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-insulin treated diabetes mellitus (NITDM)
Number of subjects: 0
Study 30612727 — intervention group
Group type: COMPARATOR
Intervention: No diabetes (non-DM)
Number of subjects: 0
Study 28601692 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-centered affective stimulation
Number of subjects: 90
Study 28601692 — intervention group
Group type: COMPARATOR
Intervention: Placebo sensory stimulation
Number of subjects: 90
Study 28601692 — intervention group
Group type: COMPARATOR
Intervention: Control sensory stimulation
Number of subjects: 90
Study 26547465 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular revascularization plus supervised exercise
Number of subjects: 212
Study 26547465 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise only
Number of subjects: 212
Study 23982032 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced protein-energy provision via the enteral route feeding protocol
Number of subjects: 1059
Study 23982032 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1059
Study 23256709 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip osteoarthritis patients
Number of subjects: 48
Study 23256709 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 48
Study 23256709 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip osteoarthritis patients with minimal joint space ≤2 mm
Number of subjects: 48
Study 23256709 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip osteoarthritis patients with minimal joint space >2 mm
Number of subjects: 48
Study 21069109 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser (LaserSmile) activation of 38% hydrogen peroxide
Number of subjects: 50
Study 21069109 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone device (HealOzone) activation of 38% hydrogen peroxide
Number of subjects: 50
Study 21069109 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-emitting diode (BT Cool whitening system) activation of 38% hydrogen peroxide
Number of subjects: 50
Study 21069109 — intervention group
Group type: EXPERIMENTAL
Intervention: Quartz-Plus activation of 38% hydrogen peroxide
Number of subjects: 50
Study 21069109 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 50
Study 17974868 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent behavioral treatment (MBT)
Number of subjects: 20
Study 17974868 — intervention group
Group type: COMPARATOR
Intervention: Sleep hygiene education (SHE)
Number of subjects: 20
Study 15097303 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 100
Study 15097303 — intervention group
Group type: COMPARATOR
Intervention: Stavudine (d4T)
Number of subjects: 100
Study 11666123 — intervention group
Group type: EXPERIMENTAL
Intervention: TTFCA (total triterpenic fraction of Centella asiatica), 60 mg twice daily for 6 weeks
Number of subjects: 40
Study 11666123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9638433 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha-interferon treatment
Number of subjects: 80
Study 9638433 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 80
Study 8053015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular artemether
Number of subjects: 0
Study 8053015 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular sulfadoxine‐pyrimethamine
Number of subjects: 0
Study 8053015 — intervention group
Group type: COMPARATOR
Intervention: Intravenous quinine
Number of subjects: 0
Study 8053015 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality
Number of subjects: 0
Study 3384975 — intervention group
Group type: EXPERIMENTAL
Intervention: Kernberg's stimulus
Number of subjects: 70
Study 3384975 — intervention group
Group type: EXPERIMENTAL
Intervention: Kohut's stimulus
Number of subjects: 70
Study 3384975 — intervention group
Group type: COMPARATOR
Intervention: Neutral content stimulus (Control)
Number of subjects: 70
Study 29550012 — intervention group
Group type: EXPERIMENTAL
Intervention: WaveOne Gold Glider
Number of subjects: 60
Study 29550012 — intervention group
Group type: EXPERIMENTAL
Intervention: PathFile
Number of subjects: 60
Study 29550012 — intervention group
Group type: EXPERIMENTAL
Intervention: K-file
Number of subjects: 60
Study 29550012 — intervention group
Group type: COMPARATOR
Intervention: No glide path preparation
Number of subjects: 60
Study 26899011 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhflex
Number of subjects: 60
Study 26899011 — intervention group
Group type: COMPARATOR
Intervention: Sutures
Number of subjects: 60
Study 24646034 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolized antibiotics (AA) given for 14 days or until extubation.
Number of subjects: 50
Study 24646034 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo given for 14 days or until extubation.
Number of subjects: 50
Study 23970790 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve block (SSNB)
Number of subjects: 64
Study 23970790 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 64
Study 19942463 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 36
Study 19942463 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush-evoked allodynia
Number of subjects: 36
Study 18043966 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANNs)
Number of subjects: 60
Study 18043966 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment by experienced clinicians
Number of subjects: 60
Study 18043966 — intervention group
Group type: COMPARATOR
Intervention: Alvarado score (score >= 6)
Number of subjects: 60
Study 18043966 — intervention group
Group type: COMPARATOR
Intervention: Alvarado score (score >= 7)
Number of subjects: 60
Study 16027801 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 250 mg/day for 7-10 days before and 6 months after angioplasty
Number of subjects: 0
Study 16027801 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol 250 mg/day for 6 months after angioplasty
Number of subjects: 0
Study 16027801 — intervention group
Group type: COMPARATOR
Intervention: Control (no probucol therapy)
Number of subjects: 0
Study 12824826 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation therapy
Number of subjects: 0
Study 12824826 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study 10224951 — intervention group
Group type: EXPERIMENTAL
Intervention: Short delay conditioning (CS presented for 15 seconds followed by US for 30 seconds)
Number of subjects: 9
Study 10224951 — intervention group
Group type: COMPARATOR
Intervention: Backward conditioning
Number of subjects: 9
Study 10224951 — intervention group
Group type: COMPARATOR
Intervention: Random control condition
Number of subjects: 9
Study 8637110 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical intervention (CEA)
Number of subjects: 825
Study 8637110 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 825
Study 1824653 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 54
Study 1824653 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 54
Study 6346782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimethidine 400 mg intramuscularly as pre-anesthetic
Number of subjects: 20
Study 6346782 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 20
Study 6346782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimethidine group
Number of subjects: 20
Study 31248751 — intervention group
Group type: EXPERIMENTAL
Intervention: NSE pre-dilatation
Number of subjects: 210
Study 31248751 — intervention group
Group type: COMPARATOR
Intervention: High pressure non-compliant balloon pre-dilatation (POBA)
Number of subjects: 210
Study 29121432 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpine climate treatment (6-week personalized integrative multidisciplinary treatment in Switzerland)
Number of subjects: 84
Study 29121432 — intervention group
Group type: COMPARATOR
Intervention: Outpatient treatment in moderate maritime climate (Netherlands)
Number of subjects: 84
Study 27838673 — intervention group
Group type: EXPERIMENTAL
Intervention: Tdap (tetanus, diphtheria, and acellular pertussis) vaccination
Number of subjects: 67
Study 27838673 — intervention group
Group type: COMPARATOR
Intervention: Tetanus-only vaccination
Number of subjects: 67
Study 24727871 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 60
Study 24727871 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 60
Study 24727871 — intervention group
Group type: EXPERIMENTAL
Intervention: Both on-pump and off-pump CABG
Number of subjects: 60
Study 21636667 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/Salmeterol combination (FP/SM) 125/25 μg, two puffs bid for 2 weeks
Number of subjects: 31
Study 21636667 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone (250 μg), two puffs bid for 2 weeks
Number of subjects: 31
Study 21636667 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/Salmeterol combination (FP/SM)
Number of subjects: 31
Study 21636667 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone (250 μg)
Number of subjects: 31
Study 20237772 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg/day OXC
Number of subjects: 27
Study 20237772 — intervention group
Group type: COMPARATOR
Intervention: 600 mg/day CBZ
Number of subjects: 27
Study 17612907 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG)
Number of subjects: 355
Study 17612907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 355
Study 15196300 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate 1000 mg
Number of subjects: 12
Study 15196300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11521982 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies to H. pylori in Group A (S-PGI <25 microg/l) and Group C (S-PGI >100 microg/l)
Number of subjects: 953
Study 11521982 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies to CagA in relation to S-PGI levels
Number of subjects: 953
Study 11521982 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibodies to CagA in relation to severity of atrophic gastritis
Number of subjects: 953
Study 9475824 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc lozenges (zinc gluconate)
Number of subjects: 0
Study 9475824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8709604 — intervention group
Group type: EXPERIMENTAL
Intervention: Guyin Decoction
Number of subjects: 60
Study 8709604 — intervention group
Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 60
Study 2501852 — intervention group
Group type: EXPERIMENTAL
Intervention: Au parenteral preparations
Number of subjects: 213
Study 2501852 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (average daily dose of 450 mg)
Number of subjects: 213
Study 78625 — intervention group
Group type: EXPERIMENTAL
Intervention: Trioxsalen baths (0.5 mg/1) for 15 minutes followed by irradiation with dysprosium lamps (Osram HQI‐TS)
Number of subjects: 18
Study 78625 — intervention group
Group type: COMPARATOR
Intervention: Ingram method (control)
Number of subjects: 18
Study 78625 — intervention group
Group type: EXPERIMENTAL
Intervention: Methoxsalen bath (1 mg/l)
Number of subjects: 18
Study 30059354 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality intervention
Number of subjects: 49
Study 27076220 — intervention group
Group type: EXPERIMENTAL
Intervention: CoCr-BAS
Number of subjects: 40
Study 27076220 — intervention group
Group type: COMPARATOR
Intervention: PtCr-EES
Number of subjects: 40
Study 27076220 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 25339740 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisaccade task in ALS patients during fMRI
Number of subjects: 12
Study 25339740 — intervention group
Group type: COMPARATOR
Intervention: Antisaccade task in age-matched controls during fMRI
Number of subjects: 12
Study 25339740 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccadic latencies in ALS patients during fMRI
Number of subjects: 12
Study 25339740 — intervention group
Group type: EXPERIMENTAL
Intervention: DLPFC activation during antisaccade preparation in ALS patients
Number of subjects: 12
Study 25339740 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased activation in supplementary eye fields and frontal eye fields in ALS patients
Number of subjects: 12
Study 23097397 — intervention group
Group type: EXPERIMENTAL
Intervention: Bt maize-fed offspring from Bt maize-fed sows
Number of subjects: 15
Study 23097397 — intervention group
Group type: EXPERIMENTAL
Intervention: Bt maize-fed pigs
Number of subjects: 15
Study 23097397 — intervention group
Group type: EXPERIMENTAL
Intervention: Pigs in the Bt/Bt group
Number of subjects: 15
Study 23097397 — intervention group
Group type: EXPERIMENTAL
Intervention: Offspring from Bt maize-fed sows
Number of subjects: 15
Study 23097397 — intervention group
Group type: EXPERIMENTAL
Intervention: Pigs on the Bt/Bt treatment
Number of subjects: 15
Study 20394489 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone cream (0.1%) once daily
Number of subjects: 50
Study 20394489 — intervention group
Group type: COMPARATOR
Intervention: Pimecrolimus cream (1%) twice daily
Number of subjects: 50
Study 18410774 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (AMI)
Number of subjects: 33
Study 18410774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 15101860 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre group (promethazine 0.1 mg kg(‐1) before anaesthesia)
Number of subjects: 90
Study 15101860 — intervention group
Group type: EXPERIMENTAL
Intervention: Post group (saline before anaesthesia, promethazine 0.1 mg kg(‐1) postoperatively)
Number of subjects: 90
Study 15101860 — intervention group
Group type: COMPARATOR
Intervention: Control group (two equivalent volumes of saline)
Number of subjects: 90
Study 15101860 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre group
Number of subjects: 90
Study 15101860 — intervention group
Group type: EXPERIMENTAL
Intervention: Post group
Number of subjects: 90
Study 15101860 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study 12448315 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery
Number of subjects: 90
Study 12448315 — intervention group
Group type: COMPARATOR
Intervention: Medically treated patients
Number of subjects: 90
Study 11273253 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyunsaturated phosphatidyl choline (PPC) 350 mg thrice daily for 6 to 8 weeks
Number of subjects: 0
Study 7650662 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-determined reintroduction of solid food within eight hours of surgery
Number of subjects: 0
Study 7650662 — intervention group
Group type: COMPARATOR
Intervention: Traditional gradual dietary expansion regimen
Number of subjects: 0
Study 2560583 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 0
Study 2560583 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 2560583 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic brain irradiation
Number of subjects: 0
Study 2560583 — intervention group
Group type: COMPARATOR
Intervention: Extensive irradiation
Number of subjects: 0
Study 807697 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nasojejunal feeding
Number of subjects: 21
Study 807697 — intervention group
Group type: COMPARATOR
Intervention: Intermittent nasogastric feeding
Number of subjects: 21
Study 30825908 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous labetalol
Number of subjects: 30
Study 30825908 — intervention group
Group type: COMPARATOR
Intervention: Oral nifedipine
Number of subjects: 30
Study 28632558 — intervention group
Group type: EXPERIMENTAL
Intervention: miTLIF (minimally invasive transforaminal lumbar interbody fusion)
Number of subjects: 187
Study 28632558 — intervention group
Group type: COMPARATOR
Intervention: oTLIF (open transforaminal lumbar interbody fusion)
Number of subjects: 187
Study 25986223 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking exercise program
Number of subjects: 60
Study 25986223 — intervention group
Group type: COMPARATOR
Intervention: Internal control group (treadmill exercise)
Number of subjects: 60
Study 23989054 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 217
Study 23989054 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 217
Study 22070475 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone plus N-acetylcysteine
Number of subjects: 174
Study 22070475 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone only
Number of subjects: 174
Study 18515458 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 55
Study 18515458 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium-valproate combination
Number of subjects: 55
Study 18515458 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 55
Study 16685043 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken diet (CD)
Number of subjects: 17
Study 16685043 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactovegetarian low‐protein diet (LPD)
Number of subjects: 17
Study 16685043 — intervention group
Group type: COMPARATOR
Intervention: Usual diet (UD)
Number of subjects: 17
Study 15573688 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorolfine nail lacquer
Number of subjects: 10
Study 15573688 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclopirox nail lacquer
Number of subjects: 10
Study 15573688 — intervention group
Group type: EXPERIMENTAL
Intervention: Tioconazole nail lacquer
Number of subjects: 10
Study 11360058 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless laparoscopic cholecystectomy (GLC)
Number of subjects: 50
Study 11360058 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy (CLC)
Number of subjects: 50
Study 9421839 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-controlled knowledge of performance (SELF)
Number of subjects: 48
Study 9421839 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary knowledge of performance (SUMMARY)
Number of subjects: 48
Study 9421839 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoked control (YOKE)
Number of subjects: 48
Study 9421839 — intervention group
Group type: COMPARATOR
Intervention: Knowledge of results only (KR)
Number of subjects: 48